Factors associated with cutaneous colonization of Mucormycetes in diabetic and non-diabetic individuals

References

1. Saud B, Chand K, Amatya N, Paudel G, Adhikari S et al. Factors associated with cutaneous colonization of mucormycetes in diabetic and non-diabetic individuals. Figshare 2023 [View Article]
   [Google Scholar]
2. Spellberg B, Edwards J, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005; 18:556–569 [View Article] [PubMed]
   [Google Scholar]
3. Center for Diseases Control and Prevention Mucormycosis. Fungal Diseases 2021 https://www.cdc.gov/fungal/diseases/mucormycosis/index.html#:~:text=Mucormycosis%20(previously%20called%20zygomycosis)%20is,to%20fight%20germs%20and%20sickness
   [Google Scholar]
4. Prakash H, Chakrabarti A. Epidemiology of mucormycosis in India. Microorganisms 2021; 9:1–12 [View Article] [PubMed]
   [Google Scholar]
5. Sharma A, Goel A. Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic. Folia Microbiol 2022; 67:363–387 [View Article] [PubMed]
   [Google Scholar]
6. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41:634–653 [View Article] [PubMed]
   [Google Scholar]
7. Kandregula S, Behura A, Behera CR, Pattnaik D, Mishra A et al. A clinical significance of fungal infections in diabetic foot ulcers. Cureus 2022; 14:e26872 [View Article] [PubMed]
   [Google Scholar]
8. Theophilus Kachi U, Victoria Nneka A, Uche E. Assessment of systemic fungal infections among diabetic patients in Enugu, Nigeria. J Infect Dis Epidemiol 2018; 4: [View Article]
   [Google Scholar]
9. Uprety S, Lamichhane B. Backgrounder series: diabetes. Herd Res Soc Dev Forum 20161–5
   [Google Scholar]
10. Khanna M, Challa S, Kabeil AS, Inyang B, Gondal FJ et al. Risk of mucormycosis in diabetes mellitus: a systematic review. Cureus 2021; 13:e18827 [View Article] [PubMed]
    [Google Scholar]
11. Clinical and Laboratory Standards Institute M44-A2 Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts. 2nd edn Approved Guideline; 2009
    [Google Scholar]
12. Stemler J, Hamed K, Salmanton-García J, Rezaei-Matehkolaei A, Gräfe SK et al. Mucormycosis in the middle east and North Africa: analysis of the FungiScope^® registry and cases from the literature. Mycoses 2020; 63:1060–1068 [View Article] [PubMed]
    [Google Scholar]
13. Afroze SN, Korlepara R, Rao GV, Madala J. Mucormycosis in a diabetic patient: a case report with an insight into its pathophysiology. Contemp Clin Dent 2017; 8:662–666 [View Article] [PubMed]
    [Google Scholar]
14. Hoenigl M, Seidel D, Carvalho A, Rudramurthy SM, Arastehfar A et al. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet Microbe 2022; 3:e543–e552 [View Article] [PubMed]
    [Google Scholar]
15. World Health Organisation Diabetes. n.d https://www.who.int/health-topics/diabetes#tab=tab_1
16. Flood D, Seiglie JA, Dunn M, Tschida S, Theilmann M et al. The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults. Lancet Healthy Longev 2021; 2:e340–e351 [View Article] [PubMed]
    [Google Scholar]
17. Saud B, Bajgain P, Paudel G, Shrestha V, Bajracharya D et al. Fungal Infection among diabetic and nondiabetic individuals in Nepal. Interdiscip Perspect Infect Dis 2020; 2020:7949868 [View Article] [PubMed]
    [Google Scholar]
18. Langford S, Trubiano JA, Saxon S, Spelman D, Morrissey CO. Mucormycete infection or colonisation: experience of an Australian tertiary referral centre. Mycoses 2016; 59:291–295 [View Article] [PubMed]
    [Google Scholar]
19. Prakash H, Ghosh AK, Rudramurthy SM, Singh P, Xess I et al. A prospective multicenter study on mucormycosis in India: epidemiology, diagnosis, and treatment. Med Mycol 2019; 57:395–402 [View Article] [PubMed]
    [Google Scholar]
20. García-Carnero LC, Mora-Montes HM. Mucormycosis and COVID-19-associated mucormycosis: insights of a deadly but neglected mycosis. J Fungi 2022; 8:445 [View Article] [PubMed]
    [Google Scholar]
21. Lawton G. You’re only as young as your immune system. New Sci 2020; 245:44–48 [View Article] [PubMed]
    [Google Scholar]
22. Gong Y, Li C, Wang C, Li J, Ding M et al. Epidemiology and mortality-associated factors of invasive fungal disease in elderly patients: a 20-year retrospective study from Southern China. Infect Drug Resist 2020; 13:711–723 [View Article] [PubMed]
    [Google Scholar]
23. Chen L, Peng W, Lan G, Long G, Yang H et al. The application of metagenomic next-generation sequencing in patients with infection or colonization caused by Lichtheimia species. Front Cell Infect Microbiol 2023; 13:1103626 [View Article] [PubMed]
    [Google Scholar]
24. Olmos JM, Hernández JL, Pariente E, Martínez J, Valero C et al. Trabecular bone score and bone quantitative ultrasound in Spanish postmenopausal women. The Camargo cohort study. Maturitas 2020; 132:24–29 [View Article] [PubMed]
    [Google Scholar]
25. Caetano LA, Faria T, Springer J, Loeffler J, Viegas C. Antifungal-resistant Mucorales in different indoor environments. Mycology 2019; 10:75–83 [View Article] [PubMed]
    [Google Scholar]